Sorry, you need to enable JavaScript to visit this website.

Chief Corporate Affairs Officer Sally Susman Discusses Political Landscape, AI at Davos

Sally, Eleanor on stage at Davos

Photo provided by Axios; Photo credit: Dani Ammann Photography

Last week, nearly 3000 leaders from over 130 countries visited Davos, Switzerland to attend the World Economic Forum’s Annual Meeting. The theme of this year’s meeting was “Collaboration for the Intelligent Ageextlink label.”

Pfizer CEO Albert Bourla was in attendance — he provided his perspective on the future of healthextlink label for the World Economic Forum and offered a recap of his experienceextlink label on LinkedIn page — and was joined by Alexandre de Germay, Pfizer’s Chief International Commercial Officer, who leaned into his new role on The Pfizer Foundation Board of Directors, and Sally Susman, Pfizer’s Chief Corporate Affairs Officer, who helped wrap up the eventful week with an engaging conversation about “The New CEO Agenda.”

On stage with Axios communication strategist and writer Eleanor Hawkins, Susman discussed her three biggest takeaways from this year’s visit to Davos, including the importance of Corporate Affairs in this “very complex and rapidly changing world,” and her own need to upskill when it comes to AI, if only to avoid any encroaching feelings of FOBO – fear of being obsolete.

The pair also discussed the changing political landscape in the United States and around the world, a topic on everyone’s mind at Davos as President Trump was sworn into office. Sally Susman provided her perspective on Pfizer’s role as the new administration takes hold.

“We're not Republican, we're not Democrat,” said Susman. “We care about two things: patients — the patients that we serve with our medicines and vaccines — and innovation; what kind of policies will help us become more innovative and support our innovative initiatives.”

Throughout the conversationextlink label, she emphasized the importance of working with President Trump, just as Pfizer has worked with President Biden, President Obama, and the many regimes that came before them.

“This is not a time to disengage, not a time, no matter what your politics are, to sit back in frustration. Engage, engage, engage,” said Pfizer’s Chief Corporate Affairs Officer. “It's my job, and probably many others in the room with similar positions, to get in there and make your case in support of your [company's] policies.”